5.085USD-2.21%Mkt Cap: 7.45M USDP/E: —Last update: 2026-06-01
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap7.45M USD
Enterprise Value5.23M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-15.85M USD
Revenue/Share—
Last Price5.085 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.95
PEG—
EV/EBITDA-0.32
EV/Revenue—
P/S—
P/B62.53
EPS (TTM)-24.12
EPS (Forward)-0.39
52W Range
1.90029% of range12.96
52W High12.96 USD
52W Low1.900 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-350.48%
ROA-183.81%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.81M USD
CapEx (TTM)18.18K USD
FCF Margin—
FCF Yield-120.37%
Net Debt-2.72M USD
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity0.07
Current Ratio0.89
Quick Ratio0.64
Book Value/Sh0.0870 USD
Cash/Share2.019 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJul 22, 2025
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)10.00 USD
Target Range10.00 USD – 10.00 USD
# Analysts1
Ownership
Shares Out.1.46M
Float1.45M
Insiders0.55%
Institutions12.03%
Short Interest
Short Ratio0.0d
Short % Float2.11%
Short % Out.2.09%
Shares Short30.58K
Short (prev mo.)58.32K
Technical
SMA 503.633 (+40.0%)
SMA 2005.703 (-10.8%)
Beta0.54
S&P 52W Chg27.94%
Avg Vol (30d)2.93M
Avg Vol (10d)130.68K
Technical Indicators
RSI (14)55.2
MACD0.3534
MACD Signal0.5061
MACD Hist.-0.1527
BB Upper8.158 USD
BB Middle5.619 USD
BB Lower3.080 USD
BB Width90.38%
ATR (14)0.6980 USD
Vol Ratio (20d)0.00x